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Background/objectives: Meaningful proﬁling of pancreatic cancer samples is particularly challenging due
to their complex cellular composition. Beyond tumor cells, surgical biopsies contain desmoplastic stroma
with inﬁltrating inﬂammatory cells, adjacent normal parenchyma, and “non-pancreatic tissues”. The risk
of misinterpretation rises when the heterogeneous cancer tissues are sub-divided into smaller fragments
for multiple analytic procedures. Pre-analytic histological evaluation is the best option to characterize
pancreatic tissue samples. Our aim was to develop a complement or alternative procedure to determine
the cellular composition of pancreatic cancerous biopsies, basing on intra-analytic molecular annotation.
A standard process for sample stratiﬁcation at a molecular level does not yet exist. Particularly in the case
of retrospective or data depository-based studies, when hematoxylin-eosin stained sections are not
available, it supports the correct interpretation of expression proﬁles.
Methods: A ﬁve-gene transcriptional signature (RNACellStrat) was deﬁned that allows cell type-speciﬁc
stratiﬁcation of pancreatic tissues. Testing biopsy material from biobanks with this procedure demon-
strated high correspondence of molecular (qRT-PCR and microarray) and histologic (hematoxylin-eosin
stain) evaluations.
Results: Notably, about a quarter of randomly selected samples (tissue fragments) were exposed as
inappropriate for subsequent clinico-pathological interpretation.
Conclusions: Via immediate intra-analytical procedure, our RNA-based stratiﬁcation RNACellStrat in-
creases the accuracy and reliability of the conclusions drawn from diagnostic and prognostic molecular
information.
Copyright © 2015, IAP and EPC. Published by Elsevier India, a division of Reed Elsevier India Pvt. Ltd. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
A major challenge in the differential analysis of pancreatic tis-
sues (healthy vs. inﬂamed vs. malignant pancreas) is the highlyre, Department of Surgery,
erg, Germany. Tel.: þ49 6221
erg.de (A. Heller), nathalia.
by Elsevier India, a division of Reedheterogeneous tissue composition. Normal pancreatic tissue con-
tains exocrine (80%) and endocrine cells, a distinct ductal system
and discrete connective tissue carrying lymphoid and blood vessels
as well as nerves [1]. In pancreatic ductal adenocarcinoma (PDAC),
this architecture is markedly changed. A varying number of tumor
cells become surrounded by desmoplastic stroma, generated by
myoﬁbroblastic stellate cells. It contains hypertrophic vessels and
nerves, diverse immune cell inﬁltrates and necrotic areas [2e6].
Also, malignant pancreatic tumors very often inﬁltrate
peripancreatic fat, lymph nodes, the biliary duct or the duodenum,
andewhen progressede the gall bladder, stomach or colon, so thatElsevier India Pvt. Ltd. This is an open access article under the CC BY-NC-ND license
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pancreatic cancer patients during collection of the biopsies.
Molecular studies require pre-analytic quantitative character-
ization of the cell types contained in a complex tumor. Usually, the
tissue specimen is evaluated by a pathologist, followed by the
diagnosis and visual annotation of the cellular composition based
on routine H&E tissue staining. However, patient material, which is
provided for non-diagnostically research purposes, is frequently cut
into several small fragments and further processed in the form of
consecutive sections with changing architecture. This increases the
risk of having varying non-tumorous/non-pancreatic proportions
in the respective cancer samples. Those samples have to be
reevaluated before analysis. Also, in studies using stored tissue
homogenates or RNA, the tissue stratiﬁcation by H&E-staining and
visual evaluation is not feasible. Furthermore, for analyses based on
already existing RNA-proﬁles, such as publically available data de-
positories, it is frequently impossible to procure the cellular
composition of the analyzed specimen and ensure accuracy of the
diagnostic (i.e. overexpression of tumor-cell speciﬁc molecules) or
prognostic assumptions.
Our aimwas to develop a simple and reliable molecular strategy
for a cellular annotation of pancreatic samples, allowing intra-
analytic adjustment and generation of comparable sets of tissue
samples. In a previous study [7], we observed that the expression of
the PNLIPRP2 gene correlated with the percentage of normal acinar
parenchyma contained in the analyzed pancreata. This observation
enabled an intra-analytical stratiﬁcation of the samples and
consequently a superior interpretation of the data, showing
immunogenicity of the pancreatic molecules. These data allowed us
to avoid overstatements in regard to PNLIPRP2 in a study dealing
with epigenetic regulation in pancreatic cancer [8], because
emergence of PNLIPRP2 among top epigenetically-silenced
pancreatic genes might rather reﬂect replacement of PNLIPRP2-
positive acini (epithelium) with PNLIPRP2-negative stroma
(mesenchyme), i.e. represent a lineage-speciﬁc but not tumor-
speciﬁc phenomenon. This encouraged us to develop a stratiﬁca-
tion procedure by employing a multi-gene marker algorithm for
cellular annotation of RNA-proﬁled data (RNACellStrat). Our
approach enables a simple, intra-analytic classiﬁcation of each
particular specimen, beyond routine H&E staining, and conse-
quently a reliable interpretation of the molecular data resulting
from biomedical studies.Material and methods
Patients and specimens
The study was performed with tissue samples obtained from
patients admitted to the Department of General, Visceral and
Transplantation Surgery, University of Heidelberg and National
Institute for Health Research, Liverpool. The samples wereTable 1
Patient information.
Female
Quantitative PCR analysis cohort Gender (n¼) 13
Age (median; IQR) 57.7 (54.1e67.2
Microarray analysis cohort Gender (n¼) 11
Age (median; IQR) 69.3 (58.6e71.8
Survival analysis cohort Gender (n¼) 37
Age (median; IQR) 61.4 (57.9e70.3
IQR: interquartile range.deposited into PancoBank (Prof. Dr. M.W. Büchler) supported by
Heidelberger Stiftung Chirurgie/HSC and by Biomaterial Bank
Heidelberg/BMBH (Prof. Dr. P. Schirmacher; BMBF grant 01EY1101).
The Pancobank started sample collection in 2001 and consists of
currently about 10,000 tissue specimens. The study was approved
by the ethical committee of the University of Heidelberg (case
number 301/2001) and conducted in accordance with the Helsinki
Declaration; written informed consent was obtained from all pa-
tients. Diagnoses were established by a pathologist according to
World Health Organization classiﬁcation 2010 [9]. Pancreatic bi-
opsies were immediately snap-frozen in liquid nitrogen and stored
at 80 C. Table 1 provides an overview of the patient cohorts used
in the study.
Samples preparation
To achieve most accurate comparability of histological and
molecular evaluations (H&E-stained tissues' images and RNA
expression proﬁles, respectively), the frozen tissue samples were
cut into 10 mm sections with a cryotom (LEICA Biosystems, Wetzlar,
Germany). After 10 serial cuts, one tissue sectionwas transferred to
a glass slide and stained with H&E. Subsequently, a pathologist
visually quantiﬁed the proportion of acinar, stromal fat, endocrine
and immune compartments in the specimen. A percentage value
was assigned to each compartment. The remaining sections were
collected for RNA isolation and transcriptional proﬁling by qRT-
PCR- or microarray-based technologies. Candidate annotation
genes are given in Tables 1 and 2.
Quantitative mRNA expression analyses by qRT-PCR
For qRT-PCR-based proﬁling, tissue sections have been pro-
cessed to mRNA using MagNA Pure system (Roche Applied Science,
Mannheim, Germany). Following cDNA synthesis, LightCycler®-
based real-time PCR was performed using the FastStart DNA SYBR
Green kit and primers obtained from Search-LC (Heidelberg, Ger-
many) as described previously [4,5,10]. The expression of each
speciﬁc gene was normalized to housekeeping gene Cyclophilin B
and presented as the number of transcripts per 10,000 copies of
Cyclophilin B (10 kCPB).
Microarray RNA expression analysis
For microarray-based proﬁling, tissue sections have been
processed to total RNA using AllPrep Isolation kit (Qiagen, Hilden,
Germany). To synthesize ﬁrst and second strand cDNA and for
amplifying biotinylated cRNA, the Illumina Totalprep RNA
Ampliﬁcation Kit (Illumina) was used [11]. Genome-wide
expression proﬁling was performed using Sentrix Human-6v3
Whole Genome Expression BeadChips (Illumina San Diego, CA,
USA). Hybridization to the BeadChip microarrays was performedMale Diagnosis
21 34 pancreatic ductal adenocarcinoma
) 60.9 (56.1e64.1)
21 24 pancreatic ductal adenocarcinoma,
1 chronic pancreatitis, 1 pancreas donor,
2 cystic adenoma, 1 cystic adenocarcinoma,
3 endocrine tumors
) 62.8 (54.2e73.6)
61 98 pancreatic ductal adenocarcinoma
) 60.9 (55.6e67.1)
Table 2
Correlation of molecular (qRT-PCR) and histological cellular annotation.
Celltype marker genes
(qRT-PCR analysis)a
Cell/tissue type at histological
validationb
Correlation
coefﬁcientc
Amylase2a Normal pancreas parenchyma 0.846**
PNLIPRP2 Normal pancreas parenchyma 0.899**
Insulin Islet cells 0.709**
CK19 Ductal/tumor cells 0.710**
MSLN Ductal/tumor cells 0.698**
Collagen1A1 Stroma 0.493*
Smacta2 Stroma 0.376*
Leptin Fat 0.802**
CD2 Inﬂammatoric inﬁltrates 0.683**
CD8 Inﬂammatoric inﬁltrates 0.608**
CD20 Inﬂammatoric inﬁltrates 0.587**
FOXp3 Inﬂammatoric inﬁltrates 0.667**
CD45 Inﬂammatoric inﬁltrates 0.716**
a The mRNA copy number of cell-type speciﬁc expression markers was
analyzed by qRT-PCR.
b The areas covered by the respective cell types as percent of the total area
upon visual quantiﬁcation of HE-stained tissue slices by a pathologist.
c The correlation coefﬁcient of expression and cellular composition is given
(Spearman-Rho coefﬁcient; *p < 0.05; **p < 0.01).
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with 20 ml GEX-HYB hybridization solution, heated, dispensed
onto the large sample port of each array and incubated at 58 C
for 18 h. Following hybridization, the samples were washed ac-
cording to the standard protocol and scanned with a BeadArray
Reader. Raw data was exported from the Beadstudio software to
R [12]. The data was quantile normalized and log2 transformed.
The threshold for background absorption was set to 4.0 and
subtracted from all values. The potential cell-speciﬁc tissue
marker probes are shown in Supplementary Table S1. Clustering
analyses and generation of the heat maps were performed using
Chipster Software [13].
Statistical analyses
Boxplots (individual gene expression values, median, inter-
quartile range) and statistical analysis of patients' survival
(KaplaneMeier curves and Log-rank test) was performed with
GraphPad Prism 5 Software (La Jolla, CA, USA). Correlation of all
expression values with all area-% values provided by a pathologist
upon visual evaluation of HE-stained tissue sections was performed
via Spearman test (two-sided) using SPSS Statistics 21 software
(IBM, New York, USA). Correlation coefﬁcients from 0 to 0.25
indicate little or no relationship between the two parameters; 0.25
to 0.50 indicate a fair degree of correlation; 0.50 to 0.75 show a
moderate to good relationship; values above 0.75 represent a very
good to excellent relationship [14].
Results
Deﬁnition of potential molecular marker genes for annotation of
cellular composition in pancreatic biopsies
A literature search was performed to identify cell-type speciﬁc
genes, which may be capable of representing the different com-
partments in pancreatic tumor samples. Under consideration were
endocrine, acinar, ductal, tumor, stromal, fat, and immune
markers. Expression of b-cell-produced insulin (INS) marked
Langerhans islets - a major component of the endocrine
compartment [15,16]. The genes encoding enzymes produced by
pancreatic acinar cells, amylase-A2-alpha (AMY2A) [17e19] and
pancreatic lipase related protein 2 (PNLIPRP2) [20,21], werechosen as markers of normal exocrine parenchyma. Cytokeratin-
19 (CK19) served as a marker for ductal epithelial cells, both
normal and transformed [22,23]. Differential overexpression of
mesothelin (MSLN) was assumed to mark only malignant ductal
epithelium [24,25]. A desmoplastic reaction is characteristic of
both inﬂammatory and cancerous pancreata. Generally, pancreatic
stellate cells are activated in these tissues, with increased smooth
muscle actin alpha (ACTA2/SMACTA2) expression as an indicator
[2,26,27]. These cells produce excessive amounts of extracellular
matrix proteins such as collagen type I (COL1A1) and ﬁbronectin
(FN1) [27,28]. These three markers were therefore used for the
identiﬁcation of stellate cells and the extracellular matrix. Leptin
(LEP) is secreted by adipocytes and serves as a marker for adipose
tissue (fat) [29,30]. To identify immune cell accumulation in tissue
samples, diverse markers representing different types of immune
cells were selected: CD45 antigen (PTPRC) is a receptor type pro-
tein tyrosine phosphatase necessary in the regulation of signal
transduction in T- and B-cells. Therefore, CD45 is a suitable
candidate to represent the collectivity of immune cells in the
tissue sample or tertiary lymphatic inclusions. We then further
characterized the immune cell compartment according to CD2,
CD8, FOXp3 and CD20 expression. Inﬁltration of these cells into
chronic pancreatitis (CP) and PDAC has been shown [31]. CD2 is a
surface antigen expressed on all peripheral blood T-cells [32e34];
CD8 antigen is found in cancer patients on cytotoxic T-cells,
mediating responses against cancer antigens [35]. Forkhead box
protein 3 (FOXp3) serves as marker for regulatory T-cells [36e38].
CD20 is a marker for B-cells [39,40].
Analysis of specimens by quantitative reverse transcription (qRT)-
PCR
Frozen pancreatic tumor tissue (34 samples) from PDAC patients
was randomly chosen from an existing Pancobank of about 10,000
pancreatic specimens. The gene expression (number of mRNA
copies per 10 kCPB) of the potential marker genes was correlated
with the area-percentage values of the different cellular compart-
ments on the slices via Spearman correlation (Table 2,
Supplementary Table S2; Supplementary Table S3). Overall, there
was good correlation between RNA-based and histological anno-
tation. Eleven of the 13 marker genes analyzed correlated with the
appropriate cell types. Only the stroma content did not ﬁt to the
expression of COL1A1 or SMACTA2.
Based on these results, the best ﬁve molecular markers were
deﬁned to as RNACellStrat panel and studied in more detail:
PNLIPRP2 for normal acinar parenchyma; INS for islets; CK19 for
ductal and PDAC epithelium; LEP for fat tissue; and CD45 for im-
mune inﬁltrates. Visualization via a boxplot indicated the presence
of outliers. Gene expression values of PNLIPRP2, LEP and CD45were
deﬁned as outliers that were distinctly separable. The values of INS
and CK19 were regarded as outliers if expression was missing (<5
mRNA copies). Four outliers were detected each for PNLIPRP2, INS,
LEP and CD45, and two for CK19 (Fig. 1A). Strong expression of
PNLIPRP2, LEP and CD45 suggested a sizeable amount of either
normal pancreatic parenchyma, fat or immune inﬁltrates in the
tissue samples. The absence of insulin expression in four samples
should reﬂect an absence of b-cells of islets; consequently, the
pancreatic nature of these four tissue samples was not certain.
Since CK19 should be usually expressed in ductal tumor cells, the
two samples lacking CK19 expression were conspicuous as well,
assuming that no tumor cells are included in the tumor sample. In
total, 18 abnormal expression values were noted for 11 tissue
samples.
We scrutinized histological data to elucidate why the 11 tissues
had such distinct proﬁles (Fig. 1B). The four samples with high
A. Heller et al. / Pancreatology 15 (2015) 423e431426
Table 3
Correlation of molecular (microarray signal intensity variations) and histological
cellular annotation.
Celltype marker genes
(microarray analysis)a
Cell/tissue type at histological
validationb
Correlation
coefﬁcientc
Amylase2a_1 Normal pancreas parenchyma 0.173
Amylase2a_2 Normal pancreas parenchyma 0.670**
PNLIPRP2 Normal pancreas parenchyma 0.664**
Insulin Islet cells 0.568**
CK19 Ductal/tumor cells 0.598**
MSLN Ductal/tumor cells 0.579**
Collagen1A1 Stroma 0.224
Smacta2 Stroma 0.087
Fibronectin1_1 Stroma 0.173
Fibronectin1_2 Stroma 0.033
Fibronectin1_3 Stroma 0.216
Leptin_1 Fat 0.018
Leptin_2 Fat 0.535**
CD45_1 Inﬂammatoric inﬁltrates 0.296
CD45_2 Inﬂammatoric inﬁltrates 0.185
CD45_3 Inﬂammatoric inﬁltrates 0.349*
CD45_4 Inﬂammatoric inﬁltrates 0.410*
a The cell-type speciﬁc gene expression markers were analyzed on a micro-
array. For some transcripts, the result of different oligonucleotide probes are
shown, indicated by an underscore followed by a number.
b Area-percentages as determined by a pathologist evaluating HE-stained tissue
section.
c The correlation coefﬁcient of expression and cellular composition is given
(Spearman-Rho coefﬁcient; *p < 0.05; **p < 0.01).
A. Heller et al. / Pancreatology 15 (2015) 423e431 427expression of PNLIPRP2 contained 34%e78% of normal pancreatic
parenchyma (Fig. 1C, I). The high LEP levels coincided with 68%e
82% inclusions of peripancreatic fat (Fig. 1C, II). The strong CD45
expression correlated with a large amount of desmoplastic stroma
inﬁltrated by immune cells (Fig. 1C, III). The two samples lacking
CK19 expression were the same ones that exhibited high LEP
expression. Three other samples also have extremely low CK19
level. Three of the four tissues, which showed no expression of INS,
had already been deﬁned as outliers because of their high fat
content. The source of the fourth sample was conﬁrmed histolog-
ically as being pancreatic (Fig.1C, IV). The lack of INS expressionwas
actually due to the absence of normal tissue areas, because the
sample consisted primarily of pancreatic tumor cells. Wewould like
to point out that only this one tissue sample had a tumor cell
percentage of over 90% and, paradoxically, did not show high CK19
expression. All other 33 samples obtained from tumor patients
contained between 0% and 40% of ductal tumor cells embedded in
desmoplastic stroma.
We noted that the ﬁve samples with low stromal content
(16 ± 1% area) but high SMACTA2 and COL1A1 values (15,272 ± 5421
and 5452 ± 2807 copies/10 kCPB) displayed high fat content
(75 ± 3% area and LEP-expression of 2197 ± 851 copies/10 kCPB;
Table S2) Exclusion of LEPhigh samples increased correspondence of
mesenchymal histological and molecular annotations (Rho ¼ 0.568
and 0.663 with p < 0.001). Thus, SMACTA2/COL1A1high-mesencynal
cells might occupy adipose tissue suggesting that prognostic
interpretation of stroma-related molecular ﬁndings requires prior
exclusion of LEPhigh samples.
In summary, RNACellStrat procedure reduced the number of
comparable tissue samples suitable for diagnostic and/or prog-
nostic correlations from 34 to 23; a reduction of 32%. The 11 con-
spicuous samples had a composition that made them inappropriate
for a comparative study since they were highly contaminated with
normal parenchyma, fat or stroma.
Independent microarray analysis
For testing the robustness and thus broad applicability of the
RNACellStrat annotation, an independent analysis was performed
on a different set of samples with a different expression proﬁling
procedure. 32 pancreatic tissue samples were selected from the
Pancobank; there were 24 samples from patients with ductal
adenocarcinoma, 1 case of chronic pancreatitis, 2 patients with
cystic adenoma, 1 sample of cystic adenocarcinoma, 1 healthy
pancreas, as well as 3 endocrine pancreas tumors.
Total RNA was isolated and used for a genome-wide expression
analysis utilizing a commercial microarray platform. As before, a
pathologist examined the composition of the H&E-stained tissue
sections. The histological data was then compared to the results of
the mRNA expression analysis. The signal intensities obtained from
17 microarray probes representing 10 genes were studied (Table 3,
Supplementary Table S4; Supplementary Table S5). The results of
six gene probes correlated signiﬁcantly with the area percentages
of corresponding cell types: expression of AMY2A and PNLIPRP2
correlated with amount of normal pancreatic parenchyma
(R ¼ 0.670, 0.664); INS with the islets (R ¼ 0.568); CK19 and MSLN
with ductal tumor cells (R ¼ 0.598, 0.579); and the signal at theFig. 1. (a) Expression values of the ﬁve RNACellStrat genes in qRT-PCR analyses of 34 PDAC ti
median and interquartile ranges are indicated. For four of the marker genes e PNLIPRP2, LEP
Two samples without CK19 expression were conspicuous as well. The 18 abnormal expressi
than one marker gene). (b þ c) Evaluation of the 11 conspicuous PDAC tissues: (b) Compariso
of the ﬁve marker genes analyzed via qRT-PCR. (c) Exemplary, the H&E-staining of cancer sa
expression (IV) are shown. Staining conﬁrmed the unusual composition of the tissue sam
inﬂammatory inﬁltrates (III) were seen, respectively. The source of the pancreatic tissue wiLEP_2 probe exhibited good correlation (R ¼ 0.535) with the
amount of fat in the tissue samples. Correlation of the signals at the
microarray oligonucleotide probes CD45_3 and CD45_4 and the
volume of inﬂammatory inﬁltrates in the H&E-stained tissue sec-
tion was signiﬁcant, but the correlation coefﬁcient showed only a
fair degree of relationship (R ¼ 0.349, 0.410). As in the PCR-
approach, stromal marker molecules (SMACTA2, COL1A1, FN1) did
not correlate with the visually assessed areas of that tissue type in
the sample. Therefore, PNLIPRP2, INS, CK19, and the LEP_2, and
CD45_4 probes were selected to perform cellular annotation.
As before, the expression of the ﬁve marker genes in the
pancreatic tissue samples was visualized via boxplots in a blinded
manner, without presenting the sample annotations; an unblinded
version is shown in Fig. 2A. There were 15 outlying values in 13
different samples. In twelve tissues, only one particular marker
gene was expressed differently, while three markers were recog-
nized as outliers in one tissue. Gene expression values of PNLIPRP2,
LEP and CD45, which are out of range of dispersion, were deﬁned as
outliers. The values of INS and CK19 are regarded as outlier if
expression is missing (<0.2 AU). Speciﬁcally, seven samples showed
high PNLIPRP2 and three samples high LEP expression. One sample
was conspicuous due to high LEP, extremely high CD45 and missing
INS expression. Another two tissues did also not express INS. For
these candidates, the tissue origin had to be further clariﬁed.
Actually, all outlier samples showed only minimal CK19 expression.
The tissue with the lowest CK19 value (¼0.58) also had the highest
LEP expression (¼3.18).
Upon un-blinding the diagnoses, it became apparent that most
‘normal’ pancreas parenchyma was observed in the healthy donor
tissue. The highest CK19 expression was observed in the samplesssue samples. Expression is displayed in relative mRNA copy numbers along the x-axis;
, insulin and CD45 e four values each were outliers with an extreme gene expression.
on values were present in 11 patient tissues (some samples were conspicuous in more
n of the visually assessed tissue compartments (areas in percent) with RNA expression
mples with a high expression of PNLIPRP2 (I), LEP (II), and CD45 (III) or missing insulin
ples: a high amount of normal pancreatic parenchyma (I), peripancreatic fat (II) and
thout insulin expression was conﬁrmed to be pancreatic PDAC tumor (IV).
Fig. 2. (a) Expression results of RNACellStrat markers in microarray experiments of patient samples with different pancreatic diseases. Results are displayed as relative mRNA copy
numbers along the x-axis; median and interquartile ranges are shown. In total, there were 15 expression outliers, representing 13 tissues. Twelve of these samples showed a
noticeable expression of one marker gene. One sample featured signiﬁcant variations of three marker genes. The different origin of the samples is indicated by a color code. (b þ c)
Evaluation of the 13 conspicuous tissues: (b) Comparison of the marker gene expression values and the histological validation (areas in percent). (c) The H&E-staining is shown of a
sample with (I) high LEP, high CD45 and no insulin expression, revealing the inclusion of a lymph node. (II) H&E-staining of a sample without insulin expression showed the
inclusion of colon tissue. The other pancreas sample without insulin expression (III) was conﬁrmed to be from a pancreas.
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A. Heller et al. / Pancreatology 15 (2015) 423e431 429from PDAC patients with the highest amount of ductal tumor cells.
The endocrine tumor patients did not overexpress INS. The clinical
pathological report of the three endocrine tumors conﬁrmed the
absence of INS, proven by immunohistochemistry. A detailed
overview about the status of the 13 conspicuous samples is pro-
vided in Fig. 2B.
The ﬁve tumor samples that exhibited high PNLIPRP2 expression
had areas of normal pancreas parenchyma that varied from 0% to
78%. The four LEP-expressing samples represented tissues con-
taining a high amount of fat (34 %e71%). Histological staining of the
one PDAC sample with the three remarkable results (high LEP, high
CD45, no INS) revealed inclusions of fat and peripancreatic lymph
node (Fig. 2C, I). Histological validation of the H&E-stained sections
of the remaining two PDAC tissue samples without INS expression
elucidated that one sample was normal colon tissue (Fig. 2C, II). In
the other specimen, the pancreatic tumor type (desmoplastic areas
and tumor cells) was conﬁrmed and the sample was not excluded
(Fig. 2C, III).
In summary, RNACellStrat procedure reduced the number of
tissue specimens from 32 to 21, a decrease of 34%. Utilizing the ﬁve
markers, it was possible to eliminate samples that were rich in fat
or normal pancreatic parenchyma and to identify non-PDAC en-
tities and tissues from non-pancreatic origin such as lymph node or
colon.
Inﬂuence of sample composition on prognosis
In order to prove the importance of performing the RNACellStrat
procedure before evaluating prognostic or diagnostic markers andFig. 3. Inﬂuence of tissue cell composition on the prognostic value of the marker molecule S
the group of high S100A2 expression (median survival 13.2 months) and 72 in the group wit
prior RNACellStrat stratiﬁcation according to cell composition showed no signiﬁcant differen
removed from the analysis. Of the remaining patients, 19 with high S100A2 expression (med
survival time 23.2 months). A log-rank test showed a signiﬁcant difference between the twto show the applicability of the established procedure, a marker-
based (S100A2) survival time analysis and signature-based PDAC
sybtypes identiﬁcation (with PDAssigner) was performed on an
independent set of Pancobank samples, with and without intra-
analytic RNACellStrat annotation. Microarray expression data of
98 PDAC patients were used for this analysis. The expression values
observed for the ﬁve RNACellStrat marker genes were considered
for stratiﬁcation.
It had been shown that patients with low S100 calcium binding
protein A2 (S100A2) expression in tumors had a better survival rate
[41,42]. In order to conﬁrm prognostic relevance of S100A2 in our
cohort, we assigned patients into two groups, S100A2high and
S100A2low (mean value as cut-off), and performed a standard
KaplaneMeier survival analysis with a subsequent Log-rank test.
Without RNACellStrat, 26 patients were allocated to the group with
high S100A2 expression, and 72 to the group with low expression,
based on the mean expression of the gene (cut-off ¼ 0.859). The
median survival of the former group was 13.2 months, that of the
latter 22.2 months. The Log-rank test showed that there is no sig-
niﬁcant difference between the two groups (p-value ¼ 0.172). The
hypothesis that low expression of the S100A2 gene is associated
with increased survival could not be conﬁrmed (Fig. 3A). With
RNACellStrat, 23 tissue samples were identiﬁed as outliers (23%).
Those tissue samples were excluded from the survival analysis
(Supplementary Fig. S1). The patient number was thus reduced
from 98 to 75. Survival of 19 patients with high S100A2 expression
(median survival time of 11.5 months) was compared to that of the
other 56 patients (median survival time of 23.2 months). The mean
S100A2 expression value of 0.893 served as the cut-off to divide the100A2. (a) From a total of 98 randomly selected patients, 26 patients were allocated in
h low expression (median survival 22.2 months). The result of a Log-rank test without
ce between the two groups. (b) After the RNACellStrat was performed, 28 samples were
ian survival 11.5 months) were compared to 56 patients with low expression (median
o groups (p-value ¼ 0.011).
A. Heller et al. / Pancreatology 15 (2015) 423e431430patient into two groups. The result was in clear contrast to that of
the ﬁrst calculation about a correlation of survival and S100A2
expression. The log-rank test showed a highly signiﬁcant difference
between the two groups (p-value ¼ 0.011; Fig. 3B), demonstrating
the impact of the RNACellStrat process on prognostic signiﬁcance.
Collisson et al. developed a 62-gene signature, designated
PDAssigner, capable of prognosis-relevant discrimination of the
three PDAC subtypes: classical, quasimesenchymal and exocrine-
like [43]. Cluster analysis of our microarray data sets showed that
this identiﬁcation by PDAC transcriptional phenotype could be
achieved only with (n ¼ 75 patients) but not without (n ¼ 98 pa-
tients) RNACellStrat clearance (Heat maps generated using Chipster
software [13] are given in Supplementary Fig. S2).
Discussion
Human tissue samples are an essential resource for oncological
research. The prevalent sources of such material are biobanks.
These facilities strive to provide well-annotated material of high
quality, meeting ISO standards requiring an extensive quality con-
trol management [44e46]; but not each analyzed tissue sample is
derived from an accredited biobank. At the same time, the need of
effective networking in multi-centric and multi-national projects is
growing with the intention of collecting a sufﬁciently large number
of cases of different origin to assess the usefulness of a marker or
drug [46,47]. To such ends, a rigorous quality assessment of tissue
samples is prerequisite.
Translational research requires tissue samples that represent a
tumor as a whole and are annotated to a high level of accuracy.
Often, this is not true for research material that is left over from
standard diagnostics. It is therefore essential to deﬁne a tissue
sample's quality very precisely before utilizing it for scientiﬁcally
motivated molecular analyses and drawing any conclusions from
their results. A precise determination of the abundance of different
cell-types in tumor tissue is crucial to assuring comparability of
samples, in particular for multicentric studies or for retrospective
analyses that are based on data from public databases.
The established pathological method of tissue stratiﬁcation is
the macroscopic evaluation, followed by the evaluation of H&E-
stained slices to deﬁne the diagnosis. It is essential to know if the
resection margins are tumor-free and lymph-nodes are affected,
which can be ascertained by the pathological examination. For
molecular research, however, the precise amount of the different
tissue types is of enormous interest. In the routine, tissue stratiﬁ-
cation is done with representative tissue slides to fulﬁll the diag-
nostic requirements, but the tissues are not necessarily prepared to
perform molecular analyses. To save biochemical standards in
molecular analysis, an additional approach for quantifying different
tissue types, the imprint cytology, was created. It has been shown
that this method is effective in eliminating samples with signiﬁcant
necrosis, but not in evaluating the quantity of tumor cells [48].
In our study, we introduced an RNA-based procedure for a
quantiﬁcation of the cell composition of pancreatic tissue samples
for molecular analyses, employing either qRT-PCR or microarray
data. In 2010, Shen-Orr and colleagues already reported that dif-
ferential gene expression patterns of diverse cell types correlate
with relative cell-type frequencies in rat brain, liver and lung [49].
In a previous study [7], we demonstrated that PNLIPRP2 gene
expression allows to predict the percentage of normal pancreatic
parenchyma found in pancreatic tumor samples. This prompted us
to create a procedure for the molecular annotation of a tissue
cellular composition, based on mRNA-expression proﬁles of a set of
cell-type marker genes (RNACellStrat). This approach is advanta-
geous in that it can be used as an internal control as long as the
mRNA-proﬁles of the ﬁve marker genes are part of the relevantstudies. Also, an internal validation of tissues can be performed, to
guarantee the molecular based tissue composition, which is
particularly important for retrospective or data depositories-based
studies.
To maximize the number of experiments that can be performed
from single specimen and to avoid repeated freeze-thaw cycles,
pancreatic biopsies used for research purposes are frequently sub-
divided into smaller tissue specimens, thus delivering different cell
composition of the individual fragments randomly selected for
molecular proﬁling. From in total 164 tissue samples that were
randomly selected from our Pancobank of some 10,000 samples, 45
would have been excluded from comparative analyses, equivalent
to about 27%. When taking into account only the PDAC-diagnosed
cohorts from qRT-PCR and microarray analyses (in total 156 sam-
ples), 43 samples which equal 28% were eliminated. RNACellStrat
allowed identiﬁcation of the samples suitable for prognostic asso-
ciations. Next to stratiﬁcation according to cellular composition, the
established method allowed the identiﬁcation of samples where
the amount of malignant cells is insufﬁcient or contain a high
amount of fat or acinar cells, or even other adjacent organs such as
colon or lymph nodes. By using only ﬁve marker genes, we
managed to stratify tumor tissues according to their cellular
composition. In consequence, 32% and 21% of the samples were
eliminated from qRT-PCR and microarray analyses, respectively.
Also, we demonstrated the applicability and importance of the
method for improving prognostic accuracy through an exemplary
survival analysis of PDAC patients. Usually, a signiﬁcant reduction
of the sample number in a study, here by 23%, leads to worsening of
its statistical power. In this case, however, the reduction led to an
increase in signiﬁcance because the suitability of the remaining
samples for prognostic correlations was proven by RNACellStrat
yielding probes of a comparable composition. Moreover, RNACell-
Strat precluded wrong prognoses for the patients with excluded
samples. Finally, our data suggested that an interpretation of
stroma-related molecular ﬁndings should be considered prior to
exclusion of LEPhigh (fat) samples because mesenchymal cells in
adipose tissues might express similar sets of marker molecules.
In conclusion, the results show that the determination of tumor
tissue composition is crucial for the interpretation of expression
proﬁles and other molecular data and inﬂuences their prognostic
value signiﬁcantly. The process represents a complement or alter-
native procedure to pre-analytic histological evaluation. In this
way, the procedure increases reliability of the results of biomedical
studies and improves prognostic accuracy while reducing the
probability of ﬁndings' misinterpretation. While the process is
optimized for a cellular annotation of pancreatic tumor tissues, the
strategy may be transferred and applicable to other diseases and
tissue types, displaying a tool to strengthen the molecular tissue
analysis.
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